Trial Profile
A Single-Dose Study to Examine the Within Subject Variability of Clexane (80 mg) s.c. in Healthy Adult Subjects Under Fasting Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Embolism; Myocardial infarction; Thromboembolism; Thrombosis; Unstable angina pectoris
- Focus Pharmacokinetics
- 26 Apr 2014 New trial record